Publication | Closed Access

NK-104, a potent new 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, enhances posttranslational catabolism of apolipoprotein B-100 and inhibits secretion of apolipoprotein B-100 and triacylglycerols from HepG2 cells

OxysterolBiochemistryMedicineHepg2 CellsApolipoprotein B-100Lipid PeroxidationReductase InhibitorLipoprotein MetabolismMetabolismPharmacologyLipid SynthesisOxidative Stress